The Valley Desk

ArticleJournal of biopharmaceutical statisticsPublished

TITE-STEIN: Time-to-event simple toxicity and efficacy interval design to accelerate phase I/II trials

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Journal of biopharmaceutical statistics
Published
Subject terms
Humans; Antineoplastic Agents; Treatment Outcome; Models, Statistical; Maximum Tolerated Dose; Dose-Response Relationship, Drug; Research Design; Time Factors; Computer Simulation; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose Finding
PubMed ID
41342593
Added to directory
Source checked

Report a correction or request removal